Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1450 (LINC01450) is a human long intergenic non-coding RNA (lincRNA) gene that transcribes an RNA molecule longer than 200 nucleotides and does not overlap any known protein-coding genes[1][5][3]. Like other lincRNAs, it does not code for a protein but may be involved in regulatory processes such as modifying chromatin, controlling transcription, regulating neighboring genes, and influencing nuclear architecture[3][7]. The specific biological or disease-associated functions of LINC01450 itself have not been well characterized in the literature as of September 2025. There is no evidence that LINC01450 is a clinically actionable target, is associated with drug interactions, or serves as a disease biomarker[1][5].
Not applicable (no drugs known to target LINC01450)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1450 (LINC01450).